Home
Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 04/10
Trade details
- Type
- Insider sale
- Amount
- $1,048,888.5
- Shares · price
- 1,815 sh · $577.90 a share
- Held after
- 44,219 sh
- Trade date
- 26/04/09
- Filed
- 26/04/10
- Days to filing
- 1 days
Sold 3.9% of holdings
- Share of holding sold
- 3.9%
United Therapeutics trades, last 26 weeks
What else happened in United Therapeutics around then
Filed or reported within 30 days of the trade day · 03/10~05/09Martine A. Rothblatt's recent trades
- Martine A. Rothblatt
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 planUnited Therapeutics
UTHR
$113.3M
209,000 sh
$113.3M
Filed 10/01
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1.1M
2,309 sh
$1.1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1M
2,135 sh
$1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$664.2K
1,395 sh
$664.2K
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$574.9K
1,200 sh
$574.9K
Filed 09/30
Traded 09/29